News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
04
2023
-
12
Achievement of Excellence and Sharing Glory | Warmly Congratulate lino Pharmaceutical on winning the grand prize and lighting up the innovative brand of Chinese Digital Intelligence Medicine!
Classification：
News
Corporate News
Recently, the 17th China Growth Pharmaceutical Enterprise Development Conference hosted by the China Pharmaceutical Materials Association was held in Xiamen, and lino pharmaceutical won two awards.
Star Products"Isosorbide Mononitrate Tablets"All the way through, won the conference" excellent brand award "crown!
Digital Intelligence Pharmaceutical Innovation Service Won "2023 Pharmaceutical Industry Brand List-Golden Deer Award"!
Glory is a reward that has been on the strength of lino pharma over the years.Technology research and development, intelligent manufacturing, cultural marketing and other aspects to make dazzling achievementsThe recognition of the company is also.Protect Life and Health with Digital MedicineThe praise of this country's responsibility.
Glory is also an incentive, an incentive for Rino Pharmaceuticals to continue to plow deeper into the chronic disease field,Strengthen innovative R & D and quality controlTo provide patients with more accurate, scientific and efficient medical service experience and health solutions.
In the future, lino pharmaceutical will continue to Do not forget your initiative mind, keeping in mind its mission,Actively Explore Digital Intelligence Pharmaceutical Products and ServicesStrengthen cooperation and exchanges with all walks of life, expand business areas,Continuously enhance brand influence and market competitivenessTo make greater contributions to the healthy development of the pharmaceutical industry.
Last article
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China